OLOPATADINE eye drops solution

Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer)

Strength: 50 mcg/ml Presentation: vial, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 50 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 1 g/5 ml; 2 g/5 ml Presentation: ampoules, 5 ml Therapeutic area: Carnitine Deficiency Innovator: Carnitor (Sigma-Tau)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)

Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex)

Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim)

Strength: 20 mg/ml Presentation: vials, 5 ml & 10 ml Therapeutic area: Relief and treatment of seasonal and perennial allergic conjunctivitis Innovator: Opticrom (Sanofi)

Strength: (3 mg+1 mg)/ml Presentation: vials, 5 ml Therapeutic area: Intraocular inflammation & ocular surface bacterial contamination Innovator: Tobradex (Alcon-Novartis)